Revolution Medicines (RVMD) News Today $54.48 +1.04 (+1.95%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$54.62 +0.14 (+0.25%) As of 10/24/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RVMD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Revolution Medicines, Inc. $RVMD Shares Bought by Allianz Asset Management GmbHOctober 24 at 4:12 AM | marketbeat.comMizuho Upgrades Revolution Medicines (NASDAQ:RVMD) to Strong-BuyOctober 23 at 7:13 AM | marketbeat.comVanguard Personalized Indexing Management LLC Has $467,000 Stock Position in Revolution Medicines, Inc. $RVMDOctober 23 at 3:45 AM | marketbeat.comRevolution Medicines: Elironrasib shows’ compelling’ antitumor activity in trialOctober 22, 2025 | msn.comRevolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C ...October 22, 2025 | markets.businessinsider.comRevolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C InhibitorOctober 22, 2025 | globenewswire.comRevolution Medicines pancreatic cancer treatment granted orphan statusOctober 21, 2025 | msn.comMizuho Begins Coverage on Revolution Medicines (NASDAQ:RVMD)October 21, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Shares Gap Up - Should You Buy?October 18, 2025 | marketbeat.comRevolution Medicines' (RVMD) Outperform Rating Reiterated at WedbushOctober 18, 2025 | marketbeat.comWedbush Reiterates Revolution Medicines (RVMD) Outperform RecommendationOctober 18, 2025 | msn.comTD Asset Management Inc Buys 181,724 Shares of Revolution Medicines, Inc. $RVMDOctober 18, 2025 | marketbeat.comRevolution Medicines stock surges after FDA grants priority voucherOctober 17, 2025 | za.investing.comRevolution Medicines price target raised to $80 from $78 at BofAOctober 17, 2025 | msn.comAchieve, Disc, Revolution among winners of initial FDA national priority vouchersOctober 17, 2025 | msn.comWCM Investment Management LLC Grows Stock Position in Revolution Medicines, Inc. $RVMDOctober 17, 2025 | marketbeat.com6,116 Shares in Revolution Medicines, Inc. $RVMD Bought by Bayforest Capital LtdOctober 17, 2025 | marketbeat.comRevolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner's National Priority Voucher Pilot ProgramOctober 16, 2025 | globenewswire.comRevolution Medicines (NASDAQ:RVMD) Insider Sells $1,213,500.00 in StockOctober 16, 2025 | marketbeat.comInsider Selling: Revolution Medicines (NASDAQ:RVMD) Insider Sells 25,000 Shares of StockOctober 16, 2025 | insidertrades.com8,423 Shares in Revolution Medicines, Inc. $RVMD Bought by Maryland State Retirement & Pension SystemOctober 15, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Earns "Sell (D-)" Rating from Weiss RatingsOctober 9, 2025 | marketbeat.comDid Leadership Moves Just Shift Revolution Medicines' (RVMD) Investment Narrative Ahead of Key Launches?October 7, 2025 | finance.yahoo.comRevolution Medicines, Inc. (NASDAQ:RVMD) Given Average Recommendation of "Moderate Buy" by AnalystsOctober 4, 2025 | marketbeat.comPublic Employees Retirement System of Ohio Makes New $1.98 Million Investment in Revolution Medicines, Inc. $RVMDOctober 3, 2025 | marketbeat.comRevolution Medicines, Inc. (RVMD) Insider Sells SharesOctober 2, 2025 | insidermonkey.comRevolution Medicines Shows Improved Relative Strength; Still Shy Of BenchmarkSeptember 30, 2025 | msn.comRevolution Medicines, Inc.: Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development OfficerSeptember 29, 2025 | finanznachrichten.deRevolution Medicines appoints Alan Sandler as CDOSeptember 29, 2025 | msn.comRevolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development OfficerSeptember 29, 2025 | globenewswire.comAtle Fund Management AB Raises Stock Position in Revolution Medicines, Inc. $RVMDSeptember 21, 2025 | marketbeat.comStrs Ohio Makes New $686,000 Investment in Revolution Medicines, Inc. $RVMDSeptember 20, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Insider Sells $98,971.20 in StockSeptember 19, 2025 | marketbeat.comInsider Selling: Revolution Medicines (NASDAQ:RVMD) CFO Sells 2,320 Shares of StockSeptember 19, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) COO Margaret Horn Sells 4,775 SharesSeptember 19, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Insider Sells $245,915.94 in StockSeptember 19, 2025 | marketbeat.comInsider Selling: Revolution Medicines (NASDAQ:RVMD) Insider Sells 13,411 Shares of StockSeptember 19, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Insider Sells $98,971.20 in StockSeptember 19, 2025 | insidertrades.comHarbor Capital Advisors Inc. Buys 22,906 Shares of Revolution Medicines, Inc. $RVMDSeptember 18, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Insider Stephen Michael Kelsey Sells 25,000 SharesSeptember 17, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Insider Sells $4,408,000.00 in StockSeptember 17, 2025 | marketbeat.comQ3 EPS Estimates for Revolution Medicines Reduced by WedbushSeptember 16, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 6,877 Shares of Revolution Medicines, Inc. $RVMDSeptember 15, 2025 | marketbeat.comIntech Investment Management LLC Has $3.81 Million Holdings in Revolution Medicines, Inc. $RVMDSeptember 15, 2025 | marketbeat.comThe Goldman Sachs Group Forecasts Strong Price Appreciation for Revolution Medicines (NASDAQ:RVMD) StockSeptember 14, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Given "Strong-Buy" Rating at Raymond James FinancialSeptember 14, 2025 | marketbeat.comWedbush Research Analysts Lower Earnings Estimates for RVMDSeptember 14, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Shares Gap Up Following Analyst UpgradeSeptember 13, 2025 | marketbeat.comWells Fargo & Company Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock PriceSeptember 13, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Price Target Raised to $77.00September 13, 2025 | marketbeat.com Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RVMD Media Mentions By Week RVMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVMD News Sentiment▼0.600.84▲Average Medical News Sentiment RVMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVMD Articles This Week▼128▲RVMD Articles Average Week Get the Latest News and Ratings for RVMD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Revolution Medicines and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies INSM News ONC News BNTX News TEVA News GMAB News SMMT News ASND News RDY News VTRS News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RVMD) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy the dip? Here’s my #1 gold stock“The most obvious opportunity in gold stocks I’ve seen in my career” While everyone is distracted by gold’s...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RVMD Stock Alerts